Noninvasive Neonatal Therapy with John Konsin of Prapela
Description
Prapela is a medical device company focused on improving newborn health. Their primary product is a specially designed mattress that uses gentle vibrations to regulate infant breathing, particularly for babies experiencing apnea of prematurity and neonatal opioid withdrawal syndrome.
CEO & co-founder, John Konsin, joins this episode to share how many newborns, especially premature babies, experience breathing irregularities, including apnea and oxygen desaturation. Prapela's innovative mattress offers a non-invasive solution than can reduce the need for additional interventions while lowering costs for hospitals.
Prapela's market potential is significant, as it addresses a common and serious issue affecting newborn infants. Building on decades of research and recent exciting clinical evidence, the Prapela journey is definitely one to track, be sure to tune in so you can be informed and inspired.
United States
